Retatrutide is an investigational peptide designed as a triple receptor agonist, activating the GLP-1, GIP, and glucagon receptors. This unique multi-pathway profile is being studied for its potential to improve glucose control, appetite regulation, and energy expenditure. With its combined action, Retatrutide has gained attention as a next-generation research peptide in the field of metabolic health and weight regulation.
GLP-1 Pathway
Researched for insulin release, glucose balance, and appetite suppression.
GIP Pathway
Investigated for insulin sensitivity, fat metabolism, and energy regulation.
Glucagon Receptor
Studied for enhancing energy expenditure and supporting fat oxidation.
